Back
Recursion Pharmaceuticals Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
RXRX
Recursion Pharmaceuticals
Last Price:
$5.74
Seasonality Move:
-20.8%
7 Day Trial
ALL ACCESS PASS
$
7
Recursion Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 24.8% based on the past 4 years of stock performance.
-
Recursion Pharmaceuticals has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Recursion Pharmaceuticals Stock Undervalued?The current Recursion Pharmaceuticals [RXRX] share price is $5.52. The Score for RXRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 24.8% based on the past 4 years of stock performance.
Recursion Pharmaceuticals Stock Rating
Sell
27
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals overpriced?
-
Recursion Pharmaceuticals has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
12.36
52-Week Low:
3.79
Prediction Charts
Market Cap:
2.2B
Price in USD:
5.52
Volume:
27.5M
Beta:
0.91
Technical Analysis
SMA50:
4.85
SMA100:
5.46
SMA200:
6.24
52-Wk Change:
-33.89%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?Yes, Recursion Pharmaceuticals is a publicly traded company.
-
What is the Recursion Pharmaceuticals stock quote today?The Recursion Pharmaceuticals stock price is 5.52 USD today.
-
How to buy Recursion Pharmaceuticals stock online?You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-27 | 5.39 | 5.03 | 5.48 | 4.98 |
| Jun-30 | 5.10 | 5.06 | 5.27 | 5.01 |
| Jul-1 | 5.00 | 5.13 | 5.44 | 4.91 |
| Jul-2 | 5.15 | 5.21 | 5.40 | 5.08 |
| Jul-3 | 5.24 | 5.27 | 5.33 | 5.15 |
| Jul-7 | 5.18 | 4.93 | 5.22 | 4.80 |
| Jul-8 | 5.01 | 5.36 | 5.63 | 5.00 |
| Jul-9 | 5.46 | 5.59 | 5.77 | 5.43 |
| Jul-10 | 5.71 | 5.72 | 5.88 | 5.57 |
| Jul-11 | 5.56 | 5.28 | 5.61 | 5.25 |
| Jul-14 | 5.25 | 5.28 | 5.42 | 5.19 |
| Jul-15 | 5.31 | 5.22 | 5.53 | 5.13 |
| Jul-16 | 5.31 | 5.39 | 5.56 | 5.21 |
| Jul-17 | 5.48 | 5.52 | 5.74 | 5.46 |
Recursion Pharmaceuticals Earnings
Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Recursion Pharmaceuticals Forecast Revenue Growth
Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.23 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.